Healeon Medical Inc   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Thousand Oaks CA United States (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2018
NCT03514537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

HALEON | Healeon Medical | Healeon Medical Inc | Robert W. Alexander, MD

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 1)

Coronavirus Infections (Phase 1)

Idiopathic Pulmonary Fibrosis (Phase 1)

Infections (Phase 1)

Lung Diseases (Phase 1)

Lung Diseases, Interstitial (Phase 1)

Pneumonia, Viral (Phase 1)

Pulmonary Alveolar Proteinosis (Phase 1)

Pulmonary Fibrosis (Phase 1)

Severe Acute Respiratory Syndrome (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 13